Literature DB >> 6732506

Boric acid single dose pharmacokinetics after intravenous administration to man.

J A Jansen, J Andersen, J S Schou.   

Abstract

Eight young adult male volunteers with a basic (alimentary) plasma boric acid concentration of less than 0.10 - 0.46 mg/l were given a single dose of boric acid (562-611 mg) by 20 min IV infusion. The plasma concentration curves, followed for 3 days, best fitted a three-compartment open model, although two subjects had to be left out due to inconstant basal plasma concentration values or failure to fit to the three-compartment model. The 120 h urinary excretion was 98.7 +/- 9.1% of dose, Cltot 54.6 +/- 8.0 ml/min/1.73 m2, t1/2 beta 21.0 +/- 4.9 h and distribution volumes V1, V2, and V3: 0.251 +/- 0.099, 0.456 +/- 0.067 and 0.340 +/- 0.128 l/kg.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732506     DOI: 10.1007/BF00316588

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  6 in total

1.  THE RENAL CLEARANCE OF SODIUM PENTABORATE IN MICE AND MEN.

Authors:  L E FARR; T KONIKOWSKI
Journal:  Clin Chem       Date:  1963-12       Impact factor: 8.327

2.  Rapid method for determination of boron in biological materials.

Authors:  A Kaczmarczyk; J R Messer; C E Peirce
Journal:  Anal Chem       Date:  1971-02       Impact factor: 6.986

3.  Unaffected blood boron levels in newborn infants treated with a boric acid ointment.

Authors:  B Friis-Hansen; B Aggerbeck; J A Jansen
Journal:  Food Chem Toxicol       Date:  1982-08       Impact factor: 6.023

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Absorption of boric acid through human skin depending on the type of vehicle.

Authors:  G Stüttgen; T Siebel; B Aggerbeck
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

6.  Gastro-intestinal absorption and in vitro release of boric acid from water-emulsifying ointments.

Authors:  J A Jansen; J S Schou; B Aggerbeck
Journal:  Food Chem Toxicol       Date:  1984-01       Impact factor: 6.023

  6 in total
  9 in total

1.  Antimicrobial activity of borate-buffered solutions.

Authors:  R D Houlsby; M Ghajar; G O Chavez
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

2.  Health impact evaluation of boron in drinking water: a geographical risk assessment in Northern France.

Authors:  Chadi Yazbeck; Wolfram Kloppmann; Roger Cottier; Josiane Sahuquillo; Ginette Debotte; Guy Huel
Journal:  Environ Geochem Health       Date:  2005-09       Impact factor: 4.609

3.  Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability.

Authors:  Tiffany M Bradke; Casey Hall; Stephen W Carper; George E Plopper
Journal:  Cell Adh Migr       Date:  2008-07-23       Impact factor: 3.405

Review 4.  Boric acid vaginal suppositories: a brief review.

Authors:  S M Prutting; J D Cerveny
Journal:  Infect Dis Obstet Gynecol       Date:  1998

5.  Activation of the EIF2α/ATF4 and ATF6 Pathways in DU-145 Cells by Boric Acid at the Concentration Reported in Men at the US Mean Boron Intake.

Authors:  Sarah E Kobylewski; Kimberly A Henderson; Kristin E Yamada; Curtis D Eckhert
Journal:  Biol Trace Elem Res       Date:  2016-09-01       Impact factor: 3.738

Review 6.  Can Carbon Quantum Dots (CQDs) or Boron Compounds be an Ultimate Solution for COVID-19 Therapy?

Authors:  Gamze Camlik; Esra Kupeli Akkol; Zelihagul Degim; Ismail Tuncer Degim
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

7.  Boron Intake and decreased risk of mortality in kidney transplant recipients.

Authors:  Daan Kremer; Adrian Post; Ulrike Seidel; Patricia Huebbe; Yvonne van der Veen; Dion Groothof; António W Gomes-Neto; Tim J Knobbe; Kai Lüersen; Michele F Eisenga; Gerjan J Navis; Gerald Rimbach; Stephan J L Bakker
Journal:  Eur J Nutr       Date:  2021-10-22       Impact factor: 5.614

8.  Cellular changes in boric acid-treated DU-145 prostate cancer cells.

Authors:  W T Barranco; C D Eckhert
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

9.  The relationship of blood- and urine-boron to boron exposure in borax-workers and usefulness of urine-boron as an exposure marker.

Authors:  B D Culver; P T Shen; T H Taylor; A Lee-Feldstein; H Anton-Culver; P L Strong
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.